Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia

NCT07402369 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Fibroids With Menorrhagia

Interventions

DRUG: CMS-D002 Capsules 10 mg
DRUG: CMS-D002 Capsules 25 mg
DRUG: CMS-D002 Capsules 50 mg
DRUG: Placebo

Sponsor

Shenzhen Kangzhe Biotechnology Co., Ltd.